Indications
Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Inalimarev
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Incb106385
Digestive System Neoplasm
Incyte Corporation
P1
CC
(43)
Incb123667
Liver Failure
Incyte Corporation
P1
CC
(43)
Incb123667
Liver Disorder
Incyte Corporation
P1
CC
(43)
Indium In 111-Dota-Daratumumab
Plasma Cell Myeloma
City of Hope Medical Center
P1
CC
(43)
Indoximod
Primary Brain Neoplasm
Theodore S. Johnson
P1
CC
(43)
Infliximab
Lung Carcinoma In Situ
M.D. Anderson Cancer Center
P1
CC
(43)
Infliximab
Lung Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Ini-822
Metabolic Dysfunction-Associated Steatohepatitis
Inipharm Australia Pty Ltd
P1
CC
(43)
Innocell Autologous Cellular Immunotherapy
Ovarian Carcinoma
PhotonPharma, Inc.
P1
CC
(43)
Inqovi
T-Cell Acute Lymphoblastic Leukemia
Massachusetts General Hospital
P1
CC
(43)
ins19 car-t cells
Lymphoid Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1
CC
(43)
int2104
B-Cell Non-Hodgkin Lymphoma
Kite, A Gilead Company
P1
CC
(43)
Interleukin 18 (Recombinant Human Mutein Clone St-067)
Plasma Cell Myeloma
University of Washington
P1
CC
(43)
Intranasal Foralumab
Primary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD
P1
CC
(43)
Intranasal Foralumab
Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD
P1
CC
(43)
Inv-1120
Metastatic Malignant Neoplasm
Shenzhen Ionova Life Sciences Co., Ltd.
P1
CC
(43)
ion269
Down Syndrome
Ionis Pharmaceuticals, Inc.
P1
CC
(43)
Iopofosine (¹³¹I)
Diffuse Intrinsic Pontine Glioma
Cellectar Biosciences, Inc.
P1
CC
(43)
Iopofosine (¹³¹I)
Brain Neoplasm
Cellectar Biosciences, Inc.
P1
CC
(43)
Iopofosine (¹³¹I)
Pediatric Lymphoma
Cellectar Biosciences, Inc.
P1
CC
(43)
Ipatasertib
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ipatasertib
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ipatasertib
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Ipatasertib
Fallopian Tube Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2501 to 2525 of 9,928 assets
Previous
Page 101 of 398
Next